Clinical Research Directory
Browse clinical research sites, groups, and studies.
Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant
Sponsor: City of Hope Medical Center
Summary
This trial uses blood samples to understand how patients' bodies process and respond to a drug called cyclophosphamide given after a donor stem cell transplant. Identifying biomarkers (molecules that can indicate normal or abnormal processes) may help researchers develop a blood test that can be used to predict how well patients will process and respond to cyclophosphamide.
Official title: Blood Samples to Identify Biomarkers for Post-Transplant Cyclophosphamide
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
72
Start Date
2018-11-13
Completion Date
2027-04-24
Last Updated
2025-07-28
Healthy Volunteers
Yes
Interventions
Biospecimen Collection-Blood
Undergo collection of blood
Biospecimen Collection-Stool
Undergo collection of stool
Locations (1)
City of Hope Medical Center
Duarte, California, United States